Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists.
Haskell-Luevano. C C; Sawyer. T K TK; Trumpp-Kallmeyer. S S; Bikker. J A JA; Humblet. C C; Gantz. I I; Hruby. V J VJ
Key Findings
- The DPhe7 and Trp9 side chains of the peptides fit into a hydrophobic pocket formed by aromatic residues in transmembrane helices 4‑7.
- The Arg8 side chain forms a hydrophilic network with polar residues in transmembrane helices 2‑3.
- These interaction patterns match the known potency and prolonged action of NDP‑MSH and MTII compared with native α‑MSH.
Practical Outcomes
- For biohackers, the study confirms why melanotan‑II is a very potent and long‑acting MC1R agonist, supporting its use for skin‑tanning or potential metabolic effects. It also highlights specific molecular features that future peptide designs could target for even better efficacy, though no new dosing guidelines are provided.
Summary
Scientists built a 3‑D computer model of the human MC1R receptor (the skin‑pigment receptor) and fitted three melanotropin peptides—including melanotan‑II—into the predicted binding site. They mapped which parts of the peptides stick to which parts of the receptor, explaining why some versions are stronger and last longer.
Abstract
Three-dimensional molecular models of the human melanocortin receptor (hMC1R) have been developed based upon the electron cryo-microscopic structure of bacteriorhodopsin and the electron density footprint of bovine rhodopsin. alpha-Melanocyte-stimulating hormone, Ac-Ser-Tyr-Ser-Met4-Glu-His-Phe7-Arg-Trp-Gly-Lys-Pro-Val-NH2 (alpha-MSH, alpha-melanotropin), and the superpotent, prolonged acting agonists, Ac-Ser-Tyr-Ser-Nle4-Glu-His-DPhe7-Arg-Trp-Gly-Lys-Pro-Val-NH2 (NDP-MSH) and Ac-Nle4-c[Asp5-His6-DPhe7-Arg8-Trp9-Lys10]-NH2 (MTII), have been modeled into the proposed binding sites with specific ligand-receptor interactions identified. The melanotropin sidechain pharmacophores, DPhe7 and Trp9, are proposed to interact with a hydrophobic network of receptor aromatic residues in transmembrane regions 4, 5, 6, and 7. In addition, a hydrophilic network involving the ligand Arg8 and polar receptor residues located in transmembrane regions 2 and 3 were identified. Biological studies on alpha-MSH, NDP-MSH, MTII, and related peptides have been correlated with the proposed hMC1R model in terms of agonism, affinity, and prolongation. Finally, limited MC1R mutagenesis studies comparing alpha-MSH and NDP-MSH are interpreted within the context of the proposed hMC1R models.
Study Information
pubmed
1996